MTOR and ovarian carcinoma: We found that the expression levels of mTOR and p70S6K1 were upregulated in cisplatin-resistant ovarian cancer cells (A2780/CP and SKOV3/CP) compared with cisplatin-sensitive cells (A2780 and SKOV3) (Figure 5A).